New technology allows patients to add daily symptoms to their health record
Researchers at the University of Manchester are to trial a system where people with rheumatoid arthritis can send their daily symptoms securely to their health record
Researchers at the University of Manchester are to trial a system where people with rheumatoid arthritis can send their daily symptoms securely to their health record
The partners will host a joint conference on ‘Protein Sciences in Drug Discovery’ in Cambridge, UK, from November 18–19, 2024
Line Stigen Raquet has joined INTEGRA Biosciences as a non-executive board member
Longtime AAPS member, Robert S. Langer, rewarded for contributions including the development of the first nano-engineered materials for the controlled release of drug molecules
This research project promises to reduce the costs of cell and gene therapy manufacturing processes, making therapies more accessible and cost-effective
Used by laboratories carrying out nucleic acid-based testing, PrimeStore MTM ensures the transport and testing process is streamlined and safe
Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization
The UK’s largest lab industry event set to break more records as it returns this autumn
Automated protocols now available for mRNA and DNA sequencing
A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways
Waters announces at ASMS 2024 that more than 40 products in its LC chemistry portfolio have obtained certification
Optimer binders will be developed for use in a cervical cancer blood test
The inaugural BOOM Summit successfully convened 500 participants from across Europe at Messe Basel
Partnership to expand applications of DNA break-mapping technology and advance understanding of genomic instability in development of the neurodegenerative disease amyotrophic lateral sclerosis
The vaccine quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor
The North Carolina-based study will continue to test enrolled newborns for hundreds of childhood-onset rare genetic conditions
Partnership aims to expand CE-IVD molecular assay offerings
The new diagnostic system, which combines optofluidics and nanopores can test for COVID-19 and Zika virus
Celebration marks 70 years since the launch of the world’s first commercially available blood gas analyzer
A study suggests that a subtype of Fusobacterium nucleatum underlies colorectal cancer growth in humans and could be useful in screening and treatments
Annual ECCMID congress is now ESCMID Global
EPA announces $1B investment through president Biden’s investing in America agenda to address PFAS in drinking water
Partnership endorses mission to facilitate career progression and support life science industry growth